<?xml version="1.0" encoding="UTF-8"?><rss version="2.0" xmlns:content="http://purl.org/rss/1.0/modules/content/"><channel><title>医药合作投融资联盟 | wechat-feeds</title><link>http://MzU2NTc4MzYyOA.favicon.privacyhide.com/favicon.ico</link><description>医药行业</description><managingEditor> (hellodword)</managingEditor><pubDate>Wed, 14 Apr 2021 13:24:43 +0800</pubDate><image><url>http://MzU2NTc4MzYyOA.favicon.privacyhide.com/favicon.ico</url><title>医药合作投融资联盟 | wechat-feeds</title><link>http://MzU2NTc4MzYyOA.favicon.privacyhide.com/favicon.ico</link><width>64</width><height>64</height></image><item><title>6.45亿美元！Spark与Senti Bio达成合作，巩固行业领先的基因治疗平台</title><link>https://mp.weixin.qq.com/s/PyY7R6k_iiw7DgeHHRhBfA</link><description></description><content:encoded><![CDATA[6.45亿美元！Spark与Senti Bio达成合作，巩固行业领先的基因治疗平台]]></content:encoded><pubDate>Wed, 14 Apr 2021 11:22:01 +0800</pubDate></item><item><title>GH Research完成1.25亿美元B轮融资</title><link>https://mp.weixin.qq.com/s/5wXRgHkRD2lcgurujxVc1g</link><description></description><content:encoded><![CDATA[GH Research完成1.25亿美元B轮融资]]></content:encoded><pubDate>Wed, 14 Apr 2021 11:22:01 +0800</pubDate></item><item><title>新锐|1亿美元B轮融资开发泛突变激酶抑制剂，解决肿瘤耐药</title><link>https://mp.weixin.qq.com/s/glvu-j_MFhu4CZpO79uD1Q</link><description></description><content:encoded><![CDATA[新锐|1亿美元B轮融资开发泛突变激酶抑制剂，解决肿瘤耐药]]></content:encoded><pubDate>Wed, 14 Apr 2021 11:22:01 +0800</pubDate></item><item><title>Arcellx完成1.15亿美元C轮融资，推进适应性和可控细胞疗法开发</title><link>https://mp.weixin.qq.com/s/apeh4wdoJ5XWIIWxTnOTLQ</link><description></description><content:encoded><![CDATA[Arcellx完成1.15亿美元C轮融资，推进适应性和可控细胞疗法开发]]></content:encoded><pubDate>Wed, 14 Apr 2021 11:22:01 +0800</pubDate></item><item><title>新锐|1.39亿美元B轮融资，礼来押注基因治疗</title><link>https://mp.weixin.qq.com/s/GcI2KRsOisD678cXbp6oFw</link><description></description><content:encoded><![CDATA[新锐|1.39亿美元B轮融资，礼来押注基因治疗]]></content:encoded><pubDate>Wed, 14 Apr 2021 11:22:01 +0800</pubDate></item><item><title>新锐|1.89亿美元融资，推进针对细胞免疫靶标的管线计划和发现平台</title><link>https://mp.weixin.qq.com/s/6y8Uk6TcvWuqI1GBbg9tiQ</link><description></description><content:encoded><![CDATA[新锐|1.89亿美元融资，推进针对细胞免疫靶标的管线计划和发现平台]]></content:encoded><pubDate>Wed, 14 Apr 2021 11:22:01 +0800</pubDate></item><item><title>重磅！微软197亿美元收购Nuance加强对医疗保健AI的关注</title><link>https://mp.weixin.qq.com/s/Bzy1D7FtSRFfr1x94iFwsQ</link><description></description><content:encoded><![CDATA[重磅！微软197亿美元收购Nuance加强对医疗保健AI的关注]]></content:encoded><pubDate>Tue, 13 Apr 2021 10:47:45 +0800</pubDate></item><item><title>Antios Therapeutics完成9600万美元B轮融资，推进乙肝新药临床</title><link>https://mp.weixin.qq.com/s/VPkgXwlB_LrV6Azs6gXTTA</link><description></description><content:encoded><![CDATA[Antios Therapeutics完成9600万美元B轮融资，推进乙肝新药临床]]></content:encoded><pubDate>Tue, 13 Apr 2021 10:47:45 +0800</pubDate></item><item><title>4.14亿欧元！赛诺菲获得一款口服IL-17A抑制剂全球权益</title><link>https://mp.weixin.qq.com/s/DJqeJmgKzcuLwngmXvLTwA</link><description></description><content:encoded><![CDATA[4.14亿欧元！赛诺菲获得一款口服IL-17A抑制剂全球权益]]></content:encoded><pubDate>Tue, 13 Apr 2021 10:47:45 +0800</pubDate></item><item><title>Avantor以10.6亿美元收购机器人玩家Ritter，拓展诊断和药物递送</title><link>https://mp.weixin.qq.com/s/-RO85UQEw-V3cqm7GYLAyg</link><description></description><content:encoded><![CDATA[Avantor以10.6亿美元收购机器人玩家Ritter，拓展诊断和药物递送]]></content:encoded><pubDate>Tue, 13 Apr 2021 10:47:45 +0800</pubDate></item><item><title>AI前沿！NVIDIA与Schrödinger合作，进一步加速全球药物研发</title><link>https://mp.weixin.qq.com/s/yMwbMA8QWb7OH4VEhI8TAA</link><description></description><content:encoded><![CDATA[AI前沿！NVIDIA与Schrödinger合作，进一步加速全球药物研发]]></content:encoded><pubDate>Tue, 13 Apr 2021 10:47:45 +0800</pubDate></item><item><title>杉互健康获红杉中国数千万元Pre-A轮融资</title><link>https://mp.weixin.qq.com/s/TImpJKvJKa1E6Cg1Hgxbpg</link><description></description><content:encoded><![CDATA[杉互健康获红杉中国数千万元Pre-A轮融资]]></content:encoded><pubDate>Tue, 13 Apr 2021 10:47:45 +0800</pubDate></item><item><title>中国高端口腔医疗领导品牌​瑞尔集团完成近2亿美元E轮融资</title><link>https://mp.weixin.qq.com/s/Ww5774c4vWesTU4cmXmozw</link><description></description><content:encoded><![CDATA[中国高端口腔医疗领导品牌​瑞尔集团完成近2亿美元E轮融资]]></content:encoded><pubDate>Tue, 13 Apr 2021 10:47:45 +0800</pubDate></item><item><title>Cresilon完成3850万美元的A-3轮融资，加速止血凝胶的商业化</title><link>https://mp.weixin.qq.com/s/Qs7uUFKHVR3Z6kHDW1dihQ</link><description></description><content:encoded><![CDATA[Cresilon完成3850万美元的A-3轮融资，加速止血凝胶的商业化]]></content:encoded><pubDate>Mon, 12 Apr 2021 09:56:06 +0800</pubDate></item><item><title>AI新药「望石智慧」完成1亿美元B及B+轮融资</title><link>https://mp.weixin.qq.com/s/8qnN3J1Fi39aAYYLuADMqw</link><description></description><content:encoded><![CDATA[AI新药「望石智慧」完成1亿美元B及B+轮融资]]></content:encoded><pubDate>Mon, 12 Apr 2021 09:56:06 +0800</pubDate></item><item><title>ValenzaBio完成7000万美元A轮融资，Fidelity领投</title><link>https://mp.weixin.qq.com/s/C9DZc5XkXFv-_qB5ULeb0w</link><description></description><content:encoded><![CDATA[ValenzaBio完成7000万美元A轮融资，Fidelity领投]]></content:encoded><pubDate>Mon, 12 Apr 2021 09:56:06 +0800</pubDate></item><item><title>Anodyne Nanotech完成420万美元种子轮融资，开发透皮微针制剂</title><link>https://mp.weixin.qq.com/s/u5ADQu71LP5__XO_2VPK_w</link><description></description><content:encoded><![CDATA[Anodyne Nanotech完成420万美元种子轮融资，开发透皮微针制剂]]></content:encoded><pubDate>Mon, 12 Apr 2021 09:56:06 +0800</pubDate></item><item><title>Remiges Ventures完成9500万美元募资，推出RDiscovery孵化器</title><link>https://mp.weixin.qq.com/s/O3LFS0CxwzVA23JW3SV5Bw</link><description></description><content:encoded><![CDATA[Remiges Ventures完成9500万美元募资，推出RDiscovery孵化器]]></content:encoded><pubDate>Mon, 12 Apr 2021 09:56:06 +0800</pubDate></item><item><title>重磅！赛诺菲以4.7亿美元收购mRNA生物技术Tidal Therapeutics</title><link>https://mp.weixin.qq.com/s/26tCUksOzjZ5kvtj_IvOaw</link><description></description><content:encoded><![CDATA[重磅！赛诺菲以4.7亿美元收购mRNA生物技术Tidal Therapeutics]]></content:encoded><pubDate>Mon, 12 Apr 2021 09:56:06 +0800</pubDate></item><item><title>重磅！Exscientia宣布首款AI设计的肿瘤免疫新药进入临床试验</title><link>https://mp.weixin.qq.com/s/C4MVpujVLYdAME_-sJKQeQ</link><description></description><content:encoded><![CDATA[重磅！Exscientia宣布首款AI设计的肿瘤免疫新药进入临床试验]]></content:encoded><pubDate>Mon, 12 Apr 2021 09:56:06 +0800</pubDate></item></channel></rss>